RxDoctor Payments Data

Latifah Sabree, MD

Family Medicine · The Villages, FLNPI 1811978059

Payments from drug & device makers

$3,669in general payments, 2019–2025

Across 93 payments — averaging $39.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$465
  • Lilly USA, LLC$446
  • Amgen$431
  • GSK$141
  • AbbVie$137
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,669100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,669 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$18,343
Medicare patients
62
Services billed
420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$103,226
OzempicSemaglutide48$77,159
JardianceEmpagliflozin41$62,198
TrulicityDulaglutide17$16,712
XareltoRivaroxaban13$13,991
Qvar RedihalerBeclomethasone Dipropionate20$10,709
Omeprazole314$9,416
Atorvastatin Calcium868$7,847
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,384
Arnuity ElliptaFluticasone Furoate16$5,353
Amlodipine Besylate548$4,306
SymbicortBudesonide/Formoterol Fumarate13$4,238
Gabapentin162$4,018
Losartan Potassium431$3,725
Levothyroxine Sodium482$3,597

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$100$103,22677 claims
Novo NordiskOzempic$1,004$77,15948 claims
Boehringer IngelheimJardiance$28$62,19841 claims
Lilly USA, LLCTrulicity$446$16,71217 claims
GSKAnoro Ellipta, Arnuity Ellipta, Shingrix$141$13,07238 claims
AstraZenecaSymbicort$465$4,23813 claims
AbbVieSynthroid$137$2,74922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in The Villages

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →